Pyxis Oncology ($PYXS) Insider Trading & Smart Money Activity

Pyxis Oncology, Inc. · Latest filing Oct 1, 2026

Pyxis Oncology, Inc. ($PYXS) has 1 insider trade on file. In the last 12 months on the open market, 1 insider bought ($0) and no insider sold, net $0.

Insider buyers (12 mo)

1

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

PYXS insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	1 · —	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PYXS insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 1, 2026	Insider	GordonMD Global Investments LP10% Owner	Buy (Open-market buy)	5.52M sh							—

1W / 1M / 6M = how PYXS moved from the trade or filing date.

Insider trading in PYXS: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
GordonMD Global Investments LP	10% Owner	1	—		Oct 1, 2026

Frequently asked questions

Are PYXS insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $0 and 0 insiders made 0 open-market sales worth $0, a net $0.

What is the latest insider trade in PYXS?

GordonMD Global Investments LP, 10% Owner filed a buy (open-market buy) of 5.52M sh on Oct 1, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.